{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:55:34Z","timestamp":1790074534615,"version":"4.0.1"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T00:00:00Z","timestamp":1510531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T00:00:00Z","timestamp":1510531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA134051"],"award-info":[{"award-number":["R01CA134051"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA189806"],"award-info":[{"award-number":["R01CA189806"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005627","name":"Thrasher Research Fund","doi-asserted-by":"publisher","award":["02833-7"],"award-info":[{"award-number":["02833-7"]}],"id":[{"id":"10.13039\/100005627","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Massachusetts Medical School (US), Center for Clinical and Translational Science, UMCCTS Pilot Project Program","award":["LTR000161-04"],"award-info":[{"award-number":["LTR000161-04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12885-017-3711-9","type":"journal-article","created":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T13:59:49Z","timestamp":1510581589000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Integrative microRNA and mRNA deep-sequencing expression profiling in endemic Burkitt lymphoma"],"prefix":"10.1186","volume":"17","author":[{"given":"Cliff I.","family":"Oduor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasin","family":"Kaymaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiprotich","family":"Chelimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana A.","family":"Otieno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Michael","family":"Ong\u2019echa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M.","family":"Moormann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,13]]},"reference":[{"key":"3711_CR1","first-page":"258","volume":"14","author":"D Burkitt","year":"1961","unstructured":"Burkitt D, O\u2019Conor GT. Malignant lymphoma in African children. I A clinical syndrome Cancer. 1961;14:258\u201369.","journal-title":"I A clinical syndrome Cancer"},{"key":"3711_CR2","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/bjs.18004619704","volume":"46","author":"D Burkitt","year":"1958","unstructured":"Burkitt D. A sarcoma involving the jaws in African children. Br J Surg. 1958;46:218\u201323.","journal-title":"Br J Surg"},{"key":"3711_CR3","first-page":"1397","volume":"60","author":"G Brady","year":"2007","unstructured":"Brady G, MacArthur GJ, Farrell PJ. Epstein-Barr virus and Burkitt lymphoma. J Clin Pathol. 2007;60:1397\u2013402.","journal-title":"J Clin Pathol"},{"key":"3711_CR4","unstructured":"Epstein MA. Historical background; Burkitt\u2019s lymphoma and Epstein-Barr virus. IARC Sci Publ. 1985:17\u201327."},{"key":"3711_CR5","doi-asserted-by":"crossref","unstructured":"Moormann A, Skiles J, Otieno J, Buckle G, Vik T. Optimal management of endemic Burkitt lymphoma: a holistic approach mindful of limited resources. BLCTT. 2014;91","DOI":"10.2147\/BLCTT.S67769"},{"key":"3711_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1750-9378-8-36","volume":"8","author":"GC Buckle","year":"2013","unstructured":"Buckle GC, Collins JP, Sumba PO, Nakalema B, Omenah D, Stiffler K, et al. Factors influencing time to diagnosis and initiation of treatment of endemic Burkitt Lymphoma among children in Uganda and western Kenya: a cross-sectional survey. Infect Agent Cancer. 2013;8:36.","journal-title":"Infect Agent Cancer"},{"key":"3711_CR7","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.1182\/blood-2013-05-498329","volume":"122","author":"G Ott","year":"2013","unstructured":"Ott G, Rosenwald A, Campo E. Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification. Blood. 2013;122:3884\u201391.","journal-title":"Blood"},{"key":"3711_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/ijc.2910170108","volume":"17","author":"L Zech","year":"1976","unstructured":"Zech L, Haglund U, Nilsson K, Klein G. Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas. Int J Cancer. 1976;17:47\u201356.","journal-title":"Int J Cancer"},{"key":"3711_CR9","doi-asserted-by":"publisher","first-page":"7824","DOI":"10.1073\/pnas.79.24.7824","volume":"79","author":"R Dalla-Favera","year":"1982","unstructured":"Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, Croce CM. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci U S A. 1982;79:7824\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3711_CR10","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1200\/JCO.2000.18.21.3707","volume":"18","author":"JL Hecht","year":"2000","unstructured":"Hecht JL, Aster JC. Molecular biology of Burkitt\u2019s lymphoma. J Clin Oncol. 2000;18:3707\u201321.","journal-title":"J Clin Oncol"},{"key":"3711_CR11","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/00043426-199122000-00019","volume":"13","author":"IT Magrath","year":"1991","unstructured":"Magrath IT. African Burkitt\u2019s Lymphoma: History, Biology, Clinical Features, and Treatment. J Pediatr Hematol Oncol. 1991;13:222.","journal-title":"J Pediatr Hematol Oncol"},{"key":"3711_CR12","doi-asserted-by":"publisher","first-page":"7837","DOI":"10.1073\/pnas.79.24.7837","volume":"79","author":"R Taub","year":"1982","unstructured":"Taub R, Kirsch I, Morton C, Lenoir G, Swan D, Tronick S, et al. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc Natl Acad Sci U S A. 1982;79:7837\u201341.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3711_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0065-230X(08)60476-5","volume":"56","author":"CA Spencer","year":"1991","unstructured":"Spencer CA, Groudine M. Control of c-myc regulation in normal and neoplastic cells. Adv Cancer Res. 1991;56:1\u201348.","journal-title":"Adv Cancer Res"},{"key":"3711_CR14","doi-asserted-by":"publisher","unstructured":"Gabay M, Li Y, Felsher DW. MYC activation is a hallmark of cancer initiation and maintenance. Cold Spring Harb Perspect Med [Internet]. 2014;4. Available from: \n                    https:\/\/doi.org\/10.1101\/cshperspect.a014241","DOI":"10.1101\/cshperspect.a014241"},{"key":"3711_CR15","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/ng.2468","volume":"44","author":"C Love","year":"2012","unstructured":"Love C, Sun Z, Jima D, Li G, Zhang J, Miles R, et al. The genetic landscape of mutations in Burkitt lymphoma. Nat Genet. 2012;44:1321\u20135.","journal-title":"Nat Genet"},{"key":"3711_CR16","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nature11378","volume":"490","author":"R Schmitz","year":"2012","unstructured":"Schmitz R, Young RM, Ceribelli M, Jhavar S, Xiao W, Zhang M, et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature. 2012;490:116\u201320.","journal-title":"Nature"},{"key":"3711_CR17","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/ng.3413","volume":"47","author":"H Kretzmer","year":"2015","unstructured":"Kretzmer H, Bernhart SH, Wang W, Haake A, Weniger MA, Bergmann AK, et al. DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control. Nat Genet. 2015;47:1316\u201325.","journal-title":"Nat Genet"},{"key":"3711_CR18","doi-asserted-by":"publisher","unstructured":"Kaymaz Y, Oduor CI, Yu H, Otieno JA, Ong\u2019echa JM, Moormann AM, et al. Comprehensive Transcriptome and Mutational Profiling of Endemic Burkitt Lymphoma Reveals EBV Type-specific Differences. Mol Cancer Res [Internet]. 2017; Available from: \n                    https:\/\/doi.org\/10.1158\/1541-7786.MCR-16-0305","DOI":"10.1158\/1541-7786.MCR-16-0305"},{"key":"3711_CR19","doi-asserted-by":"publisher","first-page":"e1005158","DOI":"10.1371\/journal.ppat.1005158","volume":"11","author":"F Abate","year":"2015","unstructured":"Abate F, Ambrosio MR, Mundo L, Laginestra MA, Fuligni F, Rossi M, et al. Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma. PLoS Pathog. 2015;11:e1005158.","journal-title":"PLoS Pathog"},{"key":"3711_CR20","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF03401587","volume":"1","author":"U Klein","year":"1995","unstructured":"Klein U, Klein G, Ehlin-Henriksson B, Rajewsky K, K\u00fcppers R. Burkitt\u2019s lymphoma is a malignancy of mature B cells expressing somatically mutated V region genes. Mol Med. 1995;1:495\u2013505.","journal-title":"Mol Med"},{"key":"3711_CR21","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1056\/NEJMoa055759","volume":"354","author":"SS Dave","year":"2006","unstructured":"Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma E-J, et al. Molecular diagnosis of Burkitt\u2019s lymphoma. N Engl J Med. 2006;354:2431\u201342.","journal-title":"N Engl J Med"},{"key":"3711_CR22","doi-asserted-by":"publisher","first-page":"a014282","DOI":"10.1101\/cshperspect.a014282","volume":"4","author":"R Schmitz","year":"2014","unstructured":"Schmitz R, Ceribelli M, Pittaluga S, Wright G, Staudt LM. Oncogenic mechanisms in Burkitt lymphoma. Cold Spring Harb Perspect Med Cold Spring Harbor Laboratory Press. 2014;4:a014282.","journal-title":"Cold Spring Harb Perspect Med Cold Spring Harbor Laboratory Press"},{"key":"3711_CR23","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3748\/wjg.v13.i4.497","volume":"13","author":"W Liu","year":"2007","unstructured":"Liu W, Mao S-Y, Zhu W-Y. Impact of tiny miRNAs on cancers. World J Gastroenterol. 2007;13:497\u2013502.","journal-title":"World J Gastroenterol"},{"key":"3711_CR24","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nrg3074","volume":"12","author":"M Esteller","year":"2011","unstructured":"Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12:861\u201374.","journal-title":"Nat Rev Genet"},{"key":"3711_CR25","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/nrg2634","volume":"10","author":"CM Croce","year":"2009","unstructured":"Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 2009;10:704\u201314.","journal-title":"Nat Rev Genet"},{"key":"3711_CR26","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrc1997","volume":"6","author":"GA Calin","year":"2006","unstructured":"Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6:857\u201366.","journal-title":"Nat Rev Cancer"},{"key":"3711_CR27","first-page":"1","volume":"452","author":"S Sassen","year":"2007","unstructured":"Sassen S, Miska EA, Caldas C. MicroRNA\u2014implications for cancer. Virchows Arch Springer-Verlag. 2007;452:1\u201310.","journal-title":"Virchows Arch Springer-Verlag"},{"key":"3711_CR28","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1038\/bcj.2012.1","volume":"2","author":"L Di Lisio","year":"2012","unstructured":"Di Lisio L, S\u00e1nchez-Beato M, G\u00f3mez-L\u00f3pez G, Rodr\u00edguez ME, Montes-Moreno S, Mollejo M, et al. MicroRNA signatures in B-cell lymphomas. Blood Cancer J. 2012;2:e57.","journal-title":"Blood Cancer J"},{"key":"3711_CR29","doi-asserted-by":"publisher","first-page":"9762","DOI":"10.1158\/0008-5472.CAN-07-2462","volume":"67","author":"VB Sampson","year":"2007","unstructured":"Sampson VB, Rong NH, Han J, Yang Q, Aris V, Soteropoulos P, et al. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res. 2007;67:9762\u201370.","journal-title":"Cancer Res"},{"key":"3711_CR30","doi-asserted-by":"publisher","unstructured":"Onnis A, De Falco G, Antonicelli G, Onorati M, Bellan C, Sherman O, et al. Alteration of microRNAs regulated by c-Myc in Burkitt lymphoma. PLoS One [Internet]. 2010;5. Available from: \n                    https:\/\/doi.org\/10.1371\/journal.pone.0012960","DOI":"10.1371\/journal.pone.0012960"},{"key":"3711_CR31","first-page":"661","volume":"33","author":"X Dai","year":"2013","unstructured":"Dai X, Chen S, Ge J, Han X, Zhou X, Wu Z, et al. Expression pattern of hsa-miR-9 and its association with BCL6 in EBV-positive and EBV-negative Burkitt lymphoma cell lines. Nan Fang Yi Ke Da Xue Xue Bao. 2013;33:661\u20136.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"3711_CR32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jpedsurg.2005.10.025","volume":"41","author":"I Gomez-Curet","year":"2006","unstructured":"Gomez-Curet I, Perkins RS, Bennett R, Feidler KL, Dunn SP, Krueger LJ. c-Myc inhibition negatively impacts lymphoma growth. J Pediatr Surg. 2006;41:207\u201311. discussion 207\u201311","journal-title":"J Pediatr Surg"},{"key":"3711_CR33","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3892\/ol.2015.4031","volume":"11","author":"S Hafsi","year":"2016","unstructured":"Hafsi S, Candido S, Maestro R, Falzone L, Soua Z, Bonavida B, et al. Correlation between the overexpression of Yin Yang 1 and the expression levels of miRNAs in Burkitt\u2019s lymphoma: A computational study. Oncol Lett. 2016;11:1021\u20135.","journal-title":"Oncol Lett"},{"key":"3711_CR34","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/leu.2011.156","volume":"25","author":"D Lenze","year":"2011","unstructured":"Lenze D, Leoncini L, Hummel M, Volinia S, Liu CG, Amato T, et al. The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma. Leukemia. 2011;25:1869\u201376.","journal-title":"Leukemia"},{"key":"3711_CR35","doi-asserted-by":"publisher","first-page":"e118","DOI":"10.1182\/blood-2010-05-285403","volume":"116","author":"DD Jima","year":"2010","unstructured":"Jima DD, Zhang J, Jacobs C, Richards KL, Dunphy CH, Choi WWL, et al. Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs. Blood. 2010;116:e118\u201327.","journal-title":"Blood"},{"key":"3711_CR36","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.immuni.2014.12.021","volume":"42","author":"OI Koues","year":"2015","unstructured":"Koues OI, Kowalewski RA, Chang L-W, Pyfrom SC, Schmidt JA, Luo H, et al. Enhancer sequence variants and transcription-factor deregulation synergize to construct pathogenic regulatory circuits in B-cell lymphoma. Immunity. 2015;42:186\u201398.","journal-title":"Immunity"},{"key":"3711_CR37","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.immuni.2010.05.009","volume":"32","author":"S Kuchen","year":"2010","unstructured":"Kuchen S, Resch W, Yamane A, Kuo N, Li Z, Chakraborty T, et al. Regulation of microRNA expression and abundance during lymphopoiesis. Immunity. 2010;32:828\u201339.","journal-title":"Immunity"},{"key":"3711_CR38","unstructured":"Andrews S. FastQC. A quality control tool for high throughput sequence data. Babraham Bioinformatics [Internet]. 2014. Available from: \n                    http:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\n                    \n                  ."},{"key":"3711_CR39","first-page":"10","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnetjournal. 2011;17:10\u20132.","journal-title":"EMBnetjournal"},{"key":"3711_CR40","unstructured":"Novocraft [Internet]. [cited 2016 Nov 3]. Available from: \n                    http:\/\/www.novocraft.com\/\n                    \n                  ."},{"key":"3711_CR41","doi-asserted-by":"crossref","unstructured":"Langmead B. Aligning short sequencing reads with Bowtie. Curr Protoc Bioinformatics. 2010;Chapter 11:Unit 11.7.","DOI":"10.1002\/0471250953.bi1107s32"},{"key":"3711_CR42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/nar\/gkr688","volume":"40","author":"MR Friedl\u00e4nder","year":"2012","unstructured":"Friedl\u00e4nder MR, Mackowiak SD, Li N, Chen W, Rajewsky N. miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades. Nucleic Acids Res. 2012;40:37\u201352.","journal-title":"Nucleic Acids Res"},{"key":"3711_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1758-907X-3-9","volume":"3","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Theurkauf WE, Weng Z, Zamore PD. Strand-specific libraries for high throughput RNA sequencing (RNA-Seq) prepared without poly(A) selection. Silence. 2012;3:9.","journal-title":"Silence"},{"key":"3711_CR44","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011;12:323.","journal-title":"BMC Bioinformatics"},{"key":"3711_CR45","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139\u201340.","journal-title":"Bioinformatics"},{"key":"3711_CR46","doi-asserted-by":"publisher","unstructured":"Leek JT. svaseq: removing batch effects and other unwanted noise from sequencing data. Nucleic Acids Res. [Internet]. 2014;42. Available from: \n                    https:\/\/doi.org\/10.1093\/nar\/gku864","DOI":"10.1093\/nar\/gku864"},{"key":"3711_CR47","doi-asserted-by":"publisher","first-page":"D68","DOI":"10.1093\/nar\/gkt1181","volume":"42","author":"A Kozomara","year":"2014","unstructured":"Kozomara A, Griffiths-Jones S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 2014;42:D68\u201373.","journal-title":"Nucleic Acids Res"},{"key":"3711_CR48","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/1471-2105-15-255","volume":"15","author":"T Wang","year":"2014","unstructured":"Wang T, Gu J, Li Y. Inferring the perturbed microRNA regulatory networks from gene expression data using a network propagation based method. BMC Bioinformatics. 2014;15:255.","journal-title":"BMC Bioinformatics"},{"key":"3711_CR49","unstructured":"TargetScanHuman 6.2 [Internet]. [cited 2016 Nov 3]. Available from: \n                    http:\/\/targetscan.org\/vert_61\/\n                    \n                  ."},{"key":"3711_CR50","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1186\/1471-2164-13-405","volume":"13","author":"LA Bovolenta","year":"2012","unstructured":"Bovolenta LA, Acencio ML, Lemke N. HTRIdb: an open-access database for experimentally verified human transcriptional regulation interactions. BMC Genomics. 2012;13:405.","journal-title":"BMC Genomics"},{"key":"3711_CR51","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1109\/TIP.2013.2253479","volume":"22","author":"B Ham","year":"2013","unstructured":"Ham B, Min D, Sohn K. A generalized random walk with restart and its application in depth up-sampling and interactive segmentation. IEEE Trans Image Process. 2013;22:2574\u201388.","journal-title":"IEEE Trans Image Process"},{"key":"3711_CR52","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1101\/sqb.2006.71.013","volume":"71","author":"I Behm-Ansmant","year":"2006","unstructured":"Behm-Ansmant I, Rehwinkel J, Izaurralde E. MicroRNAs silence gene expression by repressing protein expression and\/or by promoting mRNA decay. Cold Spring Harb Symp Quant Biol. 2006;71:523\u201330.","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"3711_CR53","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/nmeth.3485","volume":"12","author":"H Dweep","year":"2015","unstructured":"Dweep H, Gretz N. miRWalk2.0: a comprehensive atlas of microRNA-target interactions. Nat Methods. 2015;12:697.","journal-title":"Nat Methods"},{"key":"3711_CR54","first-page":"839","volume":"44","author":"H Dweep","year":"2011","unstructured":"Dweep H, Sticht C, Pandey P, Gretz N. miRWalk--database: prediction of possible miRNA binding sites by \u201cwalking\u201d the genes of three genomes. J. Biomed. Inform. Elsevier. 2011;44:839\u201347.","journal-title":"Elsevier"},{"key":"3711_CR55","doi-asserted-by":"publisher","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","volume":"4","author":"G Dennis Jr","year":"2003","unstructured":"Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003;4:P3.","journal-title":"Genome Biol"},{"key":"3711_CR56","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3389\/fmicb.2017.00501","volume":"8","author":"CI Oduor","year":"2017","unstructured":"Oduor CI, Movassagh M, Kaymaz Y, Chelimo K, Otieno J, Ong\u2019echa JM, et al. Human and Epstein-Barr Virus miRNA Profiling as Predictive Biomarkers for Endemic Burkitt Lymphoma. Front Microbiol. 2017;8:501.","journal-title":"Front Microbiol"},{"key":"3711_CR57","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nature03702","volume":"435","author":"J Lu","year":"2005","unstructured":"Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834\u20138.","journal-title":"Nature"},{"key":"3711_CR58","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00432-009-0747-5","volume":"136","author":"X-Y He","year":"2010","unstructured":"He X-Y, Chen J-X, Zhang Z, Li C-L, Peng Q-L, Peng H-M. The let-7a microRNA protects from growth of lung carcinoma by suppression of k-Ras and c-Myc in nude mice. J Cancer Res Clin Oncol. 2010;136:1023\u20138.","journal-title":"J Cancer Res Clin Oncol"},{"key":"3711_CR59","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.cell.2013.03.043","volume":"153","author":"A Helwak","year":"2013","unstructured":"Helwak A, Kudla G, Dudnakova T, Tollervey D. Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell. 2013;153:654\u201365.","journal-title":"Cell"},{"key":"3711_CR60","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1093\/nar\/gku127","volume":"42","author":"J Braun","year":"2014","unstructured":"Braun J, Misiak D, Busch B, Krohn K, H\u00fcttelmaier S. Rapid identification of regulatory microRNAs by miTRAP (miRNA trapping by RNA in vitro affinity purification). Nucleic Acids Res. 2014;42:e66.","journal-title":"Nucleic Acids Res"},{"key":"3711_CR61","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1593\/tlo.09151","volume":"2","author":"JCM Ricarte-Filho","year":"2009","unstructured":"Ricarte-Filho JCM, Fuziwara CS, Yamashita AS, Rezende E, da-Silva MJ, Kimura ET. Effects of let-7 microRNA on Cell Growth and Differentiation of Papillary Thyroid Cancer. Transl Oncologia. 2009;2:236\u201341.","journal-title":"Transl Oncologia"},{"key":"3711_CR62","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/ijc.25336","volume":"128","author":"F-F Lan","year":"2011","unstructured":"Lan F-F, Wang H, Chen Y-C, Chan C-Y, Ng SS, Li K, et al. Hsa-let-7g inhibits proliferation of hepatocellular carcinoma cells by downregulation of c-Myc and upregulation of p16(INK4A). Int J Cancer. 2011;128:319\u201331.","journal-title":"Int J Cancer"},{"key":"3711_CR63","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1261\/rna.043026.113","volume":"20","author":"Y Fan","year":"2014","unstructured":"Fan Y, Yin S, Hao Y, Yang J, Zhang H, Sun C, et al. miR-19b promotes tumor growth and metastasis via targeting TP53. RNA. 2014;20:765\u201372.","journal-title":"RNA"},{"key":"3711_CR64","doi-asserted-by":"crossref","unstructured":"Hafner M, Landthaler M, Burger L, Khorshid M, Hausser J, Berninger P, et al. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell. 2010;141:129\u2013141.","DOI":"10.1016\/j.cell.2010.03.009"},{"key":"3711_CR65","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1158\/1535-7163.MCT-08-0586","volume":"7","author":"KM Nelson","year":"2008","unstructured":"Nelson KM, Weiss GJ. MicroRNAs and cancer: past, present, and potential future. Mol Cancer Ther. 2008;7:3655\u201360.","journal-title":"Mol Cancer Ther"},{"key":"3711_CR66","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nrg2290","volume":"9","author":"W Filipowicz","year":"2008","unstructured":"Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 2008;9:102\u201314.","journal-title":"Nat Rev Genet"},{"key":"3711_CR67","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1517\/14712598.7.9.1363","volume":"7","author":"CH Lawrie","year":"2007","unstructured":"Lawrie CH. MicroRNA expression in lymphoma. Expert Opin Biol Ther. 2007;7:1363\u201374.","journal-title":"Expert Opin Biol Ther"},{"key":"3711_CR68","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.cell.2008.04.001","volume":"133","author":"JT Mendell","year":"2008","unstructured":"Mendell JT. miRiad roles for the miR-17-92 cluster in development and disease. Cell. 2008;133:217\u201322.","journal-title":"Cell"},{"key":"3711_CR69","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1038\/cdd.2013.125","volume":"20","author":"E Mogilyansky","year":"2013","unstructured":"Mogilyansky E, Rigoutsos I. The miR-17\/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease. Cell Death Differ. 2013;20:1603\u201314.","journal-title":"Cell Death Differ"},{"key":"3711_CR70","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/leu.2014.351","volume":"29","author":"K Musilova","year":"2015","unstructured":"Musilova K, Mraz M. MicroRNAs in B-cell lymphomas: how a complex biology gets more complex. Leukemia. 2015;29:1004\u201317.","journal-title":"Leukemia"},{"key":"3711_CR71","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nature03677","volume":"435","author":"KA O\u2019Donnell","year":"2005","unstructured":"O\u2019Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. c-Myc-regulated microRNAs modulate E2F1 expression. Nature. 2005;435:839\u201343.","journal-title":"Nature"},{"key":"3711_CR72","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3892\/ol.2012.609","volume":"3","author":"X Wang","year":"2012","unstructured":"Wang X, Cao L, Wang Y, Wang X, Liu N, You Y. Regulation of let-7 and its target oncogenes (Review). Oncol Lett. 2012;3:955\u201360.","journal-title":"Oncol Lett"},{"key":"3711_CR73","first-page":"27","volume":"6","author":"LC Spender","year":"2014","unstructured":"Spender LC, Inman GJ. Developments in Burkitt\u2019s lymphoma: novel cooperations in oncogenic MYC signaling. Cancer Manag Res. 2014;6:27\u201338.","journal-title":"Cancer Manag Res"},{"issue":"Pt 5","key":"3711_CR74","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1099\/0022-1317-74-5-803","volume":"74","author":"KH Vousden","year":"1993","unstructured":"Vousden KH, Crook T, Farrell PJ. Biological activities of p53 mutants in Burkitt\u2019s lymphoma cells. J Gen Virol. 1993;74(Pt 5):803\u201310.","journal-title":"J Gen Virol"},{"key":"3711_CR75","doi-asserted-by":"publisher","first-page":"6084","DOI":"10.1038\/sj.onc.1204827","volume":"20","author":"F Kuttler","year":"2001","unstructured":"Kuttler F, Am\u00e9 P, Clark H, Haughey C, Mougin C, Cahn JY, et al. c-myc box II mutations in Burkitt\u2019s lymphoma-derived alleles reduce cell-transformation activity and lower response to broad apoptotic stimuli. Oncogene. 2001;20:6084\u201394.","journal-title":"Oncogene"},{"key":"3711_CR76","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/ng.3342","volume":"47","author":"H Helgason","year":"2015","unstructured":"Helgason H, Rafnar T, Olafsdottir HS, Jonasson JG, Sigurdsson A, Stacey SN, et al. Loss-of-function variants in ATM confer risk of gastric cancer. Nat Genet. 2015;47:906\u201310.","journal-title":"Nat Genet"},{"key":"3711_CR77","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1038\/onc.2013.275","volume":"33","author":"CA Cremona","year":"2014","unstructured":"Cremona CA, Behrens A. ATM signalling and cancer. Oncogene. 2014;33:3351\u201360.","journal-title":"Oncogene"},{"key":"3711_CR78","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1084\/jem.20061563","volume":"203","author":"S Shreeram","year":"2006","unstructured":"Shreeram S, Hee WK, Demidov ON, Kek C, Yamaguchi H, Fornace AJ Jr, et al. Regulation of ATM\/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase. J Exp Med. 2006;203:2793\u20139.","journal-title":"J Exp Med"},{"key":"3711_CR79","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature04495","volume":"440","author":"AR Ramiro","year":"2006","unstructured":"Ramiro AR, Jankovic M, Callen E, Difilippantonio S, Chen H-T, KM MB, et al. Role of genomic instability and p53 in AID-induced c-myc-Igh translocations. Nature. 2006;440:105\u20139.","journal-title":"Nature"},{"key":"3711_CR80","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1038\/cdd.2014.78","volume":"21","author":"H-H Zhang","year":"2014","unstructured":"Zhang H-H, Li S-Z, Zhang Z-Y, Hu X-M, Hou P-N, Gao L, et al. Nemo-like kinase is critical for p53 stabilization and function in response to DNA damage. Cell Death Differ. 2014;21:1656\u201363.","journal-title":"Cell Death Differ"},{"key":"3711_CR81","doi-asserted-by":"publisher","first-page":"4705","DOI":"10.1091\/mbc.E05-05-0470","volume":"16","author":"T Kurahashi","year":"2005","unstructured":"Kurahashi T, Nomura T, Kanei-Ishii C, Shinkai Y, Ishii S. The Wnt-NLK signaling pathway inhibits A-Myb activity by inhibiting the association with coactivator CBP and methylating histone H3. Mol Biol Cell. 2005;16:4705\u201313.","journal-title":"Mol Biol Cell"},{"key":"3711_CR82","doi-asserted-by":"publisher","first-page":"7316","DOI":"10.18632\/oncotarget.2348","volume":"5","author":"R Jackstadt","year":"2014","unstructured":"Jackstadt R, Hermeking H. AP4 is required for mitogen- and c-MYC-induced cell cycle progression. Oncotarget. 2014;5:7316\u201327.","journal-title":"Oncotarget"},{"key":"3711_CR83","doi-asserted-by":"publisher","first-page":"15046","DOI":"10.1073\/pnas.0801773105","volume":"105","author":"P Jung","year":"2008","unstructured":"Jung P, Menssen A, Mayr D, Hermeking H. AP4 encodes a c-MYC-inducible repressor of p21. Proc Natl Acad Sci U S A. 2008;105:15046\u201351.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3711_CR84","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s13277-012-0547-4","volume":"34","author":"B-S Hu","year":"2013","unstructured":"Hu B-S, Zhao G, Yu H-F, Chen K, Dong J-H, Tan J-W. High expression of AP-4 predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy. Tumour Biol. 2013;34:271\u20136.","journal-title":"Tumour Biol"},{"key":"3711_CR85","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1084\/jem.20120812","volume":"210","author":"R Jackstadt","year":"2013","unstructured":"Jackstadt R, R\u00f6h S, Neumann J, Jung P, Hoffmann R, Horst D, et al. AP4 is a mediator of epithelial-mesenchymal transition and metastasis in colorectal cancer. J Exp Med. 2013;210:1331\u201350.","journal-title":"J Exp Med"},{"key":"3711_CR86","doi-asserted-by":"publisher","first-page":"e775","DOI":"10.1038\/cddis.2013.282","volume":"4","author":"R Jackstadt","year":"2013","unstructured":"Jackstadt R, Jung P, Hermeking H. AP4 directly downregulates p16 and p21 to suppress senescence and mediate transformation. Cell Death Dis. 2013;4:e775.","journal-title":"Cell Death Dis"},{"key":"3711_CR87","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1038\/onc.2009.258","volume":"28","author":"B Gruhne","year":"2009","unstructured":"Gruhne B, Sompallae R, Masucci MG. Three Epstein-Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints. Oncogene. 2009;28:3997\u20134008.","journal-title":"Oncogene"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-017-3711-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-017-3711-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-017-3711-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T13:18:30Z","timestamp":1589462310000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-017-3711-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,13]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3711"],"URL":"https:\/\/doi.org\/10.1186\/s12885-017-3711-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,13]]},"assertion":[{"value":"2 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical review and approval for this study was obtained from the Institutional Review Board at the University of Massachusetts Medical School, USA and the Scientific and Ethics Review Unit (SERU) at the Kenya Medical Research Institute (KEMRI), Kenya. Parents and legal guardians of the study participants provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"761"}}